Truist Securities Upgrades NovoCure Ltd. (NVCR) to Buy
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $16.76 -1.99%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
Truist Securities analyst Gregory Fraser upgraded NovoCure Ltd. (NASDAQ: NVCR) from Hold to Buy.
For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.
Shares of NovoCure Ltd. closed at $64.18 yesterday.
You May Also Be Interested In
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- JPMorgan Upgrades East Japan Railway Co (9020:JP) to Overweight
- BofA Securities Upgrades Suzano Papel & Celulose (SUZB3:BZ) (SUZ) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
